Bengaluru: Parenthood is often a vigil of observation. We watch for the first smile, the first step, and the first word. But ...

Guillermo Del Toro’s Frankenstein is now out on Netflix, with the monster (played by Jacob Elordi) shown to be far more human than his titular creator. The ending of the Netflix film differs from both ...

“The Long Walk” adaptation made a few key changes to the Stephen King story that might catch some fans off guard. The biggest change of the film came in the final moments. The winner of “The Long Walk ...

Anti-disialoganglioside (GD2)-targeted third-generation chimeric antigen receptor T cells (GD2-CART01) have shown promising efficacy in children with high-risk metastatic, relapsed, and refractory ...

When Emily's son, James, was diagnosed with neuroblastoma, pediatric cancer advocates encouraged her to travel from Washington, D.C., so James could be treated at MSK. The therapy worked, and now ...

Neuroblastoma, a pediatric cancer of the nervous system, remains the leading cause of cancer-related death in young children, particularly when the disease has spread. Despite aggressive treatment ...

Researchers at Karolinska Institutet and Lund University in Sweden have identified a new treatment strategy for neuroblastoma, an aggressive form of childhood cancer. By combining two antioxidant ...

Danyelza is now a category 2a treatment for high-risk neuroblastoma, following positive trial results and FDA approval. Clinical trials showed significant tumor shrinkage in patients, with some ...

Childhood neuroblastoma is often a fatal disease. Despite initial treatment success, most patients relapse or develop resistance to the current therapies. A new approach using a combination of two ...

A neuroblastoma patient treated with CAR T-cell therapy as a child achieved a complete response and remains in remission more than 18 years later. Researchers suggest this is the longest reported ...

An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent the longest reported remission to date in a patient treated with chimeric ...